HuagongsheHuagongshe Chemistry Print Report · For research reference only
Actarit
Orcl · ms932 · Mover · FAM79A · TPRG1L · ACTARIT · Ake him · Aktalin

Identifiers & Physical Properties
| CAS No. | 18699-02-0 |
|---|---|
| Molecular formula | C10H11NO3 |
| Average molar mass | 193.2 g/mol |
| Monoisotopic mass | 193.07389321 g/mol |
| SMILES | CC(=O)Nc1ccc(CC(=O)O)cc1 |
| InChIKey | MROJXXOCABQVEF-UHFFFAOYSA-N |
| PubChem CID | 2018 |
| ChEMBL | CHEMBL1885632 |
| ChEBI | CHEBI:31173 |
| EC No. | 242-511-3 |
| DTXSID | DTXSID0020020 |
Chemical & Physical Properties
| XLogP | 0.8 |
|---|---|
| Topological polar surface area | 66.4 |
| Hydrogen bond donors | 2 |
| Hydrogen bond acceptors | 3 |
| Rotatable bonds | 3 |
| Heavy atoms | 14 |
| Formal charge | 0 |
| Complexity | 219 |
| Drugs | Pharmaceuticals -> Metabolite of Mirabegron |
| Solubility | >29 [ug/mL] (The mean of the results at pH 7.4)DMSO, Ethanol, Methanol |
| Collision Cross Section | 143.5 Ų [M+Na]+ [CCS Type: DTBuffer gas: N2Ionization: ESI+Dataset: TOXCASTSource Identifier: DTXSID0020020] |
| Melting point | 173-175°C |
| Boiling point | 449.1±28.0 °C(Predicted) |
| Density | 1.288±0.06 g/cm3(Predicted) |
| Storage conditions | Sealed in dry,Room Temperature |
| Physical state | Solid |
| pKa (acidity coefficient) | 4.34±0.10(Predicted) |
| Color | White to Off-White |
| Merck | 14,133 |
| CAS DataBase Reference | 18699-02-0(CAS DataBase Reference) |
| FDA UNII | HW5B6351RZ |
| GHS pictogram | GHS07 |
| Signal word | Warning |
| GHS hazard statements | H302-H315-H319-H335 |
| GHS precautionary statements | P261-P305+P351+P338 |
| Safety statements (S) | 24/25 |
| RTECS number | CY1542000 |
| Customs code | 29163990 |
| Toxicity | LD50 in male, female mice, male, female rats (mg/kg): 1.06, 1.30, 1.95, 2.03 i.p.5.68, 5.48, 5.48, 6.12 s.c.15.3, 14.7, 14.8, 15.4 orally (Toshida) |
Safety & Regulations
| GHS classification | WarningH315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory. |
|---|---|
| Hazard Classes and Categories | Skin Irrit. 2 (100%) |
| RTECS number | CY1542000 |
| Customs code | 29163990 |
| Toxicity | LD50 in male, female mice, male, female rats (mg/kg): 1.06, 1.30, 1.95, 2.03 i.p.5.68, 5.48, 5.48, 6.12 s.c.15.3, 14.7, 14.8, 15.4 orally (Toshida) |
| Signal word | Warning |
| GHS pictogram | GHS07 |
| Safety statements (S) | 24/25 |
| GHS hazard statements | H302-H315-H319-H335 |
| GHS precautionary statements | P261-P305+P351+P338 |
Applications & Uses
Description
Actarit is an orally administered disease-modifying antirheumatic drug launched in Japan. Although its structure resembles that of non-steroidal anti-inflammatory drugs, it has no effect on experimental acute inflammation and has no analgesic or antipyretic effects. Its preventative and therapeutic effects on adjuvant arthritis are mediated via modulation of production and serum level of interleukin-2 which enhances production of suppressor T-cells to the immune system, thereby, preventing development of articular lesions.
Uses
Antiarthritic
Uses
Chronic rheumatoid arthritis